Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
  1. 4 Open-market sale President, CEO sold 15,309 shares at $43.26 ($662,267)
  2. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 3,363 shares at $43.26 ($145,483)
  3. 4 Open-market sale Chief Medical Officer sold 4,219 shares at $43.26 ($182,514)
  4. 4 Open-market sale CHIEF LEGAL OFFICER sold 2,983 shares at $43.26 ($129,045)
  5. 4 Open-market sale Director sold 3,900 shares at $49.58 ($193,343)
  6. 4 Other disposition Director disposed of 11,068 shares (other)
  7. 4 Planned sale Chief Medical Officer sold 1,500 shares at $50.00 ($75,000)
  8. 4 Planned sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $50.00 ($500,000)
  9. 4 Planned sale CHIEF LEGAL OFFICER sold 10,000 shares at $51.00 ($510,000)
  10. 4 Planned sale CHIEF LEGAL OFFICER sold 22,641 shares at an average $45.38 ($1,027,425)
  11. 4 Planned sale CHIEF FINANCIAL OFFICER sold 15,725 shares at an average $44.85 ($705,333)
  12. 4 Planned sale CHIEF LEGAL OFFICER sold 8,240 shares at $29.00 ($238,960)
  13. 4 Exercise or conversion Director acquired 1,300 shares (option exercise)
  14. 4 Planned sale Director sold 10,231 shares at an average $19.62 ($200,714)
  15. 4 Planned sale Director sold 20,925 shares at an average $23.57 ($493,191)
  16. 4 Planned sale Director sold 3,015 shares at $23.97 ($72,270)
  17. 4 Planned sale Director sold 3,015 shares at $23.97 ($72,270)
  18. 4 Exercise or conversion Director acquired 7,330 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 6,030 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 6,030 shares (option exercise)

Page 3 of 15 · 298 filings